<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput xmlns:ns2="local" hits="1" offset="0" totalResults="1"><Filters total="48"><Filter label="Trial Technologies" name="trialTechnologies" total="0"></Filter><Filter label="Indications" name="indications" total="1"><FilterOption id="3122" count="1" label="Mild cognitive impairment"></FilterOption></Filter><Filter label="Endpoint Index" name="trialEndpointIndex" total="8"><FilterOption id="19896" count="1" label="Dementia - Assessment of Dementia by Specific Scales/Scores"></FilterOption><FilterOption id="19960" count="1" label="Dementia - Assessment of Depression Severity by Specific Criteria - Assessment by HAM D"></FilterOption><FilterOption id="19860" count="1" label="Dementia - Assessment of Neuropsychological Function - Assessment by Mini-Mental State Examination (MMSE)"></FilterOption><FilterOption id="22218" count="1" label="Dementia - Assessment of Psychiatric Symptoms - Assessment by Neuropsychological Test Battery (NTB)"></FilterOption><FilterOption id="19943" count="1" label="Dementia - Assessment of Vital Signs"></FilterOption><FilterOption id="19935" count="1" label="Dementia - Assessment of adverse events"></FilterOption><FilterOption id="19857" count="1" label="Dementia - Cognitive, Global and Functional Assessments"></FilterOption><FilterOption id="19903" count="1" label="Dementia - Patient Reported Outcomes/Quality of Life Assessments - Assessment of quality of sleep"></FilterOption></Filter><Filter label="Trial Drug Phase Highest" name="trialDrugPhaseHighest" total="0"></Filter><Filter label="Trial Company Sponsor" name="trialCompaniesSponsor" total="1"><FilterOption id="CM28314" count="1" label="Enzymotec Ltd"></FilterOption></Filter><Filter label="Trial Recruitment Status" name="trialRecruitmentStatus" total="1"><FilterOption id="6" count="1" label="Terminated"></FilterOption></Filter><Filter label="Trial Commercially Significant" name="trialIsCommerciallySignificant" total="1"><FilterOption id="NO" count="1" label="No"></FilterOption></Filter><Filter label="Trial Indications Pioneer" name="trialIndicationsPioneer" total="0"></Filter><Filter label="Registry Id" name="trialRegistries" total="1"><FilterOption id="1000" count="1" label="CT.gov"></FilterOption></Filter><Filter label="Trial Reason for Discontinuation" name="trialReasonForDiscontinuation" total="1"><FilterOption id="5" count="1" label="Patient Enrollment Issues"></FilterOption></Filter><Filter label="Active Controls" name="trialActiveControls" total="0"></Filter><Filter label="Exclusion Criteria Index" name="trialExclusionCriteriaIndex" total="23"><FilterOption id="15797" count="1" label="Dementia - Immunocompromised Subjects - Subjects immunocompromised with cancer/malignancy"></FilterOption><FilterOption id="15822" count="1" label="Dementia - Subjects co-morbid with Cerebrovascular Disorders/Diseases - Subjects co-morbid with stroke/transient ischemic attack"></FilterOption><FilterOption id="15895" count="1" label="Dementia - Subjects co-morbid with Psychiatric Disease/Disorder - Subjects co-morbid with substance abuse disorders"></FilterOption><FilterOption id="15807" count="1" label="Dementia - Subjects co-morbid with Psychiatric Disease/Disorder - Subjects with depressive disorder"></FilterOption><FilterOption id="15789" count="1" label="Dementia - Subjects co-morbid with Respiratory Diseases/Disorders - Subjects co-morbid with pulmonary diseases/disorders"></FilterOption><FilterOption id="15788" count="1" label="Dementia - Subjects co-morbid with cardiovascular diseases/disorders"></FilterOption><FilterOption id="15793" count="1" label="Dementia - Subjects co-morbid with endocrine/metabolic diseases/disorders"></FilterOption><FilterOption id="15791" count="1" label="Dementia - Subjects co-morbid with hepatobiliary disorders/diseases - Subjects co-morbid with hepatic diseases/disorders"></FilterOption><FilterOption id="15794" count="1" label="Dementia - Subjects co-morbid with inflammatory disorders"></FilterOption><FilterOption id="15823" count="1" label="Dementia - Subjects co-morbid with neurological disorders/diseases - Subjects co-morbid with epilepsy/seizures"></FilterOption><FilterOption id="15818" count="1" label="Dementia - Subjects co-morbid with neurological disorders/diseases - Subjects with head trauma/migraine or other forms of headache"></FilterOption><FilterOption id="15792" count="1" label="Dementia - Subjects co-morbid with renal disease/disorder"></FilterOption><FilterOption id="15772" count="1" label="Dementia - Subjects on Protocol Prohibited Drugs - Subjects receiving/history of antiglutamatergic drugs/NMDA receptor antagonist"></FilterOption><FilterOption id="15770" count="1" label="Dementia - Subjects on Protocol Prohibited Drugs - Subjects receiving/history of protocol prohibited acetyl cholinesterase inhibitors"></FilterOption><FilterOption id="15786" count="1" label="Dementia - Subjects on Protocol Prohibited Drugs - Subjects receiving/history of surgery/transplant"></FilterOption><FilterOption id="15784" count="1" label="Dementia - Subjects on Protocol Prohibited Drugs - Subjects receiving/history of vitamin/dietary supplements"></FilterOption><FilterOption id="15778" count="1" label="Dementia - Subjects on Protocol Prohibited Drugs - Subjects with a history/current use of protocol prohibited psychotropics"></FilterOption><FilterOption id="15764" count="1" label="Dementia - Subjects with Abnormal Laboratory Findings"></FilterOption><FilterOption id="15808" count="1" label="Dementia - Subjects with Co-morbid Conditions - Subjects co-morbid with bipolar disorder"></FilterOption><FilterOption id="15795" count="1" label="Dementia - Subjects with Co-morbid Conditions - Subjects co-morbid with hematological disease/disorders"></FilterOption><FilterOption id="15868" count="1" label="Dementia - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"></FilterOption><FilterOption id="15838" count="1" label="Dementia - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients"></FilterOption><FilterOption id="15864" count="1" label="Dementia - Subjects with Protocol Specified Participation Status - Subjects not suitable to participate as per investigator's discretion"></FilterOption></Filter><Filter label="Trial Date Enrollment End By Month" name="trialDateEnrollmentEndByMonth" total="0"></Filter><Filter label="Funder Type" name="trialFunderType" total="1"><FilterOption id="CMP" count="1" label="Company"></FilterOption></Filter><Filter label="Trial Region" name="trialRegions" total="2"><FilterOption id="MENA" count="1" label="Middle East &amp; North Africa"></FilterOption><FilterOption id="USCA" count="1" label="US &amp; Canada"></FilterOption></Filter><Filter label="Patient Segment Index" name="trialPatientSegmentIndex" total="1"><FilterOption id="9983" count="1" label="Dementia - Subjects at risk of developing disease - Subjects with mild cognitive impairment"></FilterOption></Filter><Filter label="Primary Completion Filter by Month" name="trialPrimaryCompletionDateByMonth" total="1"><FilterOption count="1" label="201712"></FilterOption></Filter><Filter label="Trial Country" name="trialCountries" total="2"><FilterOption id="IL" count="1" label="Israel"></FilterOption><FilterOption id="US" count="1" label="US"></FilterOption></Filter><Filter label="Trial Patient Selection" name="trialTermsPatientSelection" total="2"><FilterOption id="EAAAD" count="1" label="Aged Adults (65-79 yrs)"></FilterOption><FilterOption id="EAELD" count="1" label="Elderly Adults (80 and over)"></FilterOption></Filter><Filter label="Trial Terms Design" name="trialTermsDesign" total="6"><FilterOption id="SSTINV" count="1" label="Interventional"></FilterOption><FilterOption id="SIMMBD" count="1" label="Multiple Blind"></FilterOption><FilterOption id="SISPRL" count="1" label="Parallel Assignment"></FilterOption><FilterOption id="SICPLC" count="1" label="Placebo Control"></FilterOption><FilterOption id="SIARND" count="1" label="Randomized"></FilterOption><FilterOption id="SIPTRE" count="1" label="Treatment"></FilterOption></Filter><Filter label="Trial Source" name="trialSources" total="1"><FilterOption id="CTGOVOTHERS" count="1" label="ClinicalTrials.gov and others"></FilterOption></Filter><Filter label="Trial Actions Secondary Interventions Primary" name="trialActionsSecondaryInterventionsPrimary" total="0"></Filter><Filter label="Trial Endpoint Achieved" name="trialEndpointsAchieved" total="0"></Filter><Filter label="Endpoint Index Secondary" name="trialEndpointIndexSecondary" total="7"><FilterOption id="19896" count="1" label="Dementia - Assessment of Dementia by Specific Scales/Scores"></FilterOption><FilterOption id="19960" count="1" label="Dementia - Assessment of Depression Severity by Specific Criteria - Assessment by HAM D"></FilterOption><FilterOption id="19860" count="1" label="Dementia - Assessment of Neuropsychological Function - Assessment by Mini-Mental State Examination (MMSE)"></FilterOption><FilterOption id="22218" count="1" label="Dementia - Assessment of Psychiatric Symptoms - Assessment by Neuropsychological Test Battery (NTB)"></FilterOption><FilterOption id="19943" count="1" label="Dementia - Assessment of Vital Signs"></FilterOption><FilterOption id="19935" count="1" label="Dementia - Assessment of adverse events"></FilterOption><FilterOption id="19903" count="1" label="Dementia - Patient Reported Outcomes/Quality of Life Assessments - Assessment of quality of sleep"></FilterOption></Filter><Filter label="Biomarker" name="trialBiomarkerNames" total="0"></Filter><Filter label="Trial Terms Endpoint" name="trialTermsEndpoint" total="2"><FilterOption id="SIEEFC" count="1" label="Efficacy"></FilterOption><FilterOption id="SIESFT" count="1" label="Safety"></FilterOption></Filter><Filter label="Trial Interventions Primary In Regimen Name Display" name="trialInterventionsPrimaryInRegimenNameDisplay" total="0"></Filter><Filter label="Trial Document Source" name="trialDocumentSource" total="1"><FilterOption id="PR" count="1" label="Press Releases"></FilterOption></Filter><Filter label="Trial Interventions Primary Alone Name Display" name="trialInterventionsPrimaryAloneNameDisplay" total="0"></Filter><Filter label="Trial Interventions Control In Regimen Name Display" name="trialInterventionsControlInRegimenNameDisplay" total="0"></Filter><Filter label="Trial Category" name="trialCategory" total="1"><FilterOption id="11" count="1" label="Dietary supplement"></FilterOption></Filter><Filter label="Trial Outcome Available" name="trialOutcomesAvailable" total="1"><FilterOption id="NO" count="1" label="No"></FilterOption></Filter><Filter label="Trial Actions Primary Interventions Primary" name="trialActionsPrimaryInterventionsPrimary" total="0"></Filter><Filter label="Trial Company Collaborator" name="trialCompaniesCollaborator" total="0"></Filter><Filter label="Trial Actions Secondary Interventions Control" name="trialActionsSecondaryInterventionsControl" total="0"></Filter><Filter label="Biomarker Type" name="trialBiomarkerTypes" total="0"></Filter><Filter label="Biomarker Role" name="trialBiomarkerRoles" total="0"></Filter><Filter label="Interventions" name="trialInterventions" total="0"></Filter><Filter label="Endpoint Index Primary" name="trialEndpointIndexPrimary" total="1"><FilterOption id="19857" count="1" label="Dementia - Cognitive, Global and Functional Assessments"></FilterOption></Filter><Filter label="Sponsors/Collaborators" name="trialCompanies" total="1"><FilterOption id="CM28314" count="1" label="Enzymotec Ltd"></FilterOption></Filter><Filter label="Last Changed Date By Day" name="trialDateChangeLastByDay" total="1"><FilterOption count="1" label="2019-01-26"></FilterOption></Filter><Filter label="Trial Date End By Month" name="trialDateEndByMonth" total="1"><FilterOption count="1" label="201712"></FilterOption></Filter><Filter label="Trial Date Start By Month" name="trialDateStartByMonth" total="1"><FilterOption count="1" label="201409"></FilterOption></Filter><Filter label="Trial Phase" name="trialPhase" total="1"><FilterOption id="PNA" count="1" label="Phase Not Applicable"></FilterOption></Filter><Filter label="Inclusion Criteria Index" name="trialInclusionCriteriaIndex" total="8"><FilterOption id="18021" count="1" label="Dementia - Protocol Specified Other Inclusion Criteria - Subjects able to communicate in the language specified in the protocol"></FilterOption><FilterOption id="17914" count="1" label="Dementia - Subjects at Risk of Developing Disease - Subjects with mild cognitive impairment"></FilterOption><FilterOption id="17959" count="1" label="Dementia - Subjects by disease severity"></FilterOption><FilterOption id="17967" count="1" label="Dementia - Subjects with Normal/Acceptable Functional Criteria - Subjects with normal/acceptable auditory function"></FilterOption><FilterOption id="17968" count="1" label="Dementia - Subjects with Normal/Acceptable Functional Criteria - Subjects with normal/acceptable visual function"></FilterOption><FilterOption id="17977" count="1" label="Dementia - Subjects with Normal/Acceptable Neurological/Neuropsychological Assessments"></FilterOption><FilterOption id="18020" count="1" label="Dementia - Subjects with Protocol Specified Compliance Status - Subjects able to comply with the study protocol procedures/ requirements"></FilterOption><FilterOption id="18019" count="1" label="Dementia - Subjects with Protocol Specified Participation Status - Subjects willing/able to provide informed consent/assent"></FilterOption></Filter><Filter label="Trial Interventions Control Alone Name Display" name="trialInterventionsControlAloneNameDisplay" total="0"></Filter><Filter label="Trial Actions Primary Interventions Control" name="trialActionsPrimaryInterventionsControl" total="0"></Filter><Filter label="Trial Indications Adverse" name="trialIndicationsAdverse" total="0"></Filter></Filters><SearchResults><Trial Id="252278"><Indications><Indication>Mild cognitive impairment</Indication></Indications><CompaniesSponsor><Company>Enzymotec Ltd</Company></CompaniesSponsor><Countries><Country>US</Country><Country>Israel</Country></Countries><DateChangeLast>2019-01-26T00:00:00Z</DateChangeLast><DateEnd>2017-12-25T00:00:00Z</DateEnd><DateStart>2014-09-30T00:00:00Z</DateStart><Identifiers><Identifier>NCT02211560</Identifier><Identifier>Vayacog_002</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>phosphatidylserine supplement alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>97</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Terminated</RecruitmentStatus><Teaser>The primary objective of this 24-month, multicenter, double-blind, randomized, placebo-controlled study was to evaluate the long-term efficacy and safety of phosphatidylserine (PS) on cognitive abilities in Mild Cognitive Impairment (MCI) [ 1707371 ].</Teaser><TrialCategories><Category>Dietary supplement</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Placebo Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Dementia - Assessment of Dementia by Specific Scales/Scores</EndpointIndex><EndpointIndex>Dementia - Assessment of Depression Severity by Specific Criteria - Assessment by HAM D</EndpointIndex><EndpointIndex>Dementia - Assessment of Neuropsychological Function - Assessment by Mini-Mental State Examination (MMSE)</EndpointIndex><EndpointIndex>Dementia - Assessment of Psychiatric Symptoms - Assessment by Neuropsychological Test Battery (NTB)</EndpointIndex><EndpointIndex>Dementia - Assessment of Vital Signs</EndpointIndex><EndpointIndex>Dementia - Assessment of adverse events</EndpointIndex><EndpointIndex>Dementia - Cognitive, Global and Functional Assessments</EndpointIndex><EndpointIndex>Dementia - Patient Reported Outcomes/Quality of Life Assessments - Assessment of quality of sleep</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment</TitleDisplay><PatientSegmentTerms><PatientSegment>Dementia - Subjects at risk of developing disease - Subjects with mild cognitive impairment</PatientSegment></PatientSegmentTerms><PrimaryCompletionDate type="Actual">2017-12-25T00:00:00Z</PrimaryCompletionDate><TrialDuration>38 Months</TrialDuration><NumberOfSites>15</NumberOfSites><ContactNames><Name>Yehudit Aharon, MD</Name></ContactNames></Trial></SearchResults></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput>